Weight loss from a GLP-1 class medication isn't all fat. In the STEP 1 body composition substudy, roughly 39% of the weight lost was lean mass, which includes muscle. That number tracks what happens in most rapid weight loss, medication or not. Muscle matters because it drives strength, glucose handling, bone loading, and the metabolic rate you live on after the medication stops. Three things change the ratio: enough protein, resistance training 2 to 3 days a week, and a rate of loss slow enough for the body to hold onto what it has. At Vitality Dartmouth, our collaborating NP or MD prescribes and monitors the medication. I build the strength program and the nutrition targets around it, and we track body composition and lab markers instead of guessing from the scale. The goal isn't the fastest number on a scale. It's keeping the muscle you spent decades building.
Does the medication cause muscle loss, or does the weight loss?
This is the question that gets flattened in most of what you'll read online, and the distinction changes what you do about it.
When the body is in a sustained calorie deficit, it doesn't draw exclusively from fat. It pulls from both fat mass and fat-free mass, and fat-free mass includes skeletal muscle along with water, glycogen, connective tissue, and organ mass. That's true of a low-calorie diet, a bariatric procedure, and a GLP-1 class medication. Researchers have described this pattern for decades in ordinary caloric restriction, long before these medications existed.
What's different with GLP-1 receptor agonists is the pace and the appetite suppression. The medications work in part by slowing gastric emptying and acting on appetite signaling in the brain, which means people eat considerably less without white-knuckling it. That's the therapeutic effect. It's also the mechanism that makes accidental undereating of protein easy, because when total intake drops by a third, protein usually drops with it unless someone is deliberately steering.
The STEP 1 substudy published in the New England Journal of Medicine reported that participants lost lean body mass along with fat mass, while the proportion of lean mass to total body mass went up. Both of those things are true at once, and marketing on either side of the debate tends to quote only one. The SURMOUNT-1 trial showed a comparable pattern with dual-agonist therapy.
More recent work is starting to test whether the ratio is modifiable rather than fixed. A 2025 case series in PubMed Central described preservation of lean soft tissue in patients on GLP-1 and GLP-1/GIP therapy who were supported with structured protein and resistance training. A case series is early evidence, not proof, and it should be read that way. But it points in the same direction as the general weight-loss literature: the lean-mass share of weight lost responds to what you do alongside the deficit.
So the honest answer is that the medication isn't uniquely destroying muscle. Rapid weight loss without protein and loading does that, and these medications make rapid weight loss much easier to achieve.
Why does lean mass matter more after 40?
Muscle isn't only about how you look in a shirt. It's metabolically active tissue that does specific jobs.
Skeletal muscle is the largest site of glucose disposal in the body. Less of it generally means a smaller buffer for handling carbohydrate load. Muscle also produces the mechanical loading that signals bone to maintain density, which matters a great deal for women moving through perimenopause and the years after, when the estrogen-driven protection of bone changes. And muscle underwrites the unglamorous things that decide independence later: getting off the floor, carrying groceries in one trip, catching yourself on a stair.
There's also the after. Most people don't stay on a weight-loss medication forever. Resting metabolic rate correlates with fat-free mass, so someone who arrives at their goal weight with meaningfully less muscle than they started with is maintaining that weight on a smaller engine. That's a harder maintenance problem, and it's the one nobody plans for at the start.
None of this argues against the medications. It argues for treating body composition, not scale weight, as the outcome that matters.
How much protein does muscle retention take?
Research on preserving lean tissue during weight loss, summarized well in this review in Advances in Nutrition, consistently points at higher protein intakes than standard dietary guidance recommends. The commonly cited range in that literature sits well above the RDA, and it's paired with resistance training rather than standing alone.
The practical problem on a GLP-1 class medication isn't knowing the target. It's hitting it when appetite is suppressed and early fullness arrives 4 bites into a meal. What tends to work in practice:
Protein gets eaten first at every meal, before the rest of the plate. Meals get smaller and more frequent rather than large and skipped. Liquid protein covers the gap on days when solid food is genuinely unappealing, which happens most often in the first week or two after a dose increase. And intake gets tracked for a stretch, because almost nobody estimates their own protein accurately.
Your individual target depends on your body size, your kidney function, your training, and your medical history, which is exactly why this belongs in a program with a provider and lab work behind it rather than a number you pull off a podcast. If you have kidney disease or any condition affecting protein handling, this conversation has to happen with your prescribing provider first.
What kind of training actually protects muscle?
Resistance training is the signal that tells the body the muscle is still needed. Without that signal, a calorie deficit reads as a reason to shed expensive tissue.
The training doesn't have to be complicated or heroic. Two to three sessions a week covering the major movement patterns, pushing, pulling, hinging, squatting, and carrying, done with enough load to be challenging in the last few repetitions, does the majority of the work. Progression matters more than variety. Adding a little weight or a rep over time is the whole mechanism.
Cardio still belongs in the picture for cardiovascular and metabolic reasons. It just doesn't substitute for loading. A lot of people on a weight-loss medication add walking, feel better, and never touch a weight, then wonder later why strength dropped.
This is the piece I own personally. My CF-L2 background means the training side of the program is built and coached rather than handed over as a PDF, and it's scaled to where someone actually is, which is often "hasn't lifted in 15 years."
How would you know if you're losing muscle instead of fat?
The bathroom scale can't tell you. It reports one number and hides the composition of it entirely.
What gives a usable picture is measuring body composition over time rather than weight alone, watching strength numbers in the gym, which fall early when lean tissue is going, and running lab markers alongside the medication as part of medical supervision. We use genomic and biomarker testing at the clinic to inform how a program gets built, and we recheck rather than set it once and assume.
Two clarifications matter here. Testing informs a program. It doesn't diagnose disease, and it isn't a screening substitute for the care your primary care physician or specialist provides. And I'm an RN. I don't prescribe, diagnose, or independently order diagnostics. Our collaborating NP or MD prescribes the medication, orders the labs, and monitors the clinical course. I build the program, coach the training, and hold people to the nutrition plan.
What does medical supervision change about any of this?
A weight-loss medication obtained without ongoing clinical oversight is a prescription with no one watching what it does to you.
Supervision means someone screens whether you're an appropriate candidate before anything starts, monitors side effects and adjusts, tracks the labs that matter as your intake drops, and coordinates with the rest of your care. It also means someone is watching the rate of loss, which is one of the few levers that reliably shifts the fat-to-lean ratio. Faster is not better here.
One point on honesty in this category, because the marketing around it is a mess. Some medications used in weight management are prescribed off-label, meaning for a use outside the FDA-approved labeling, which is legal and common in medicine but should be disclosed to you plainly. Separately, some agents circulating in the weight-loss space are investigational, meaning they have not been approved by the FDA for any use, and compounded preparations are not FDA-approved products and are not reviewed by the FDA for safety or effectiveness. Any candidate at this clinic is screened by a provider, and the regulatory status of whatever is being discussed gets stated out loud on the call, not buried. You can read the FDA's own consumer information on medications containing semaglutide.
Is this different for women in perimenopause?
The mechanics are the same. The context isn't.
Through perimenopause and into the postmenopausal years, changing hormonal signaling coincides with shifts in body composition, bone density, and how the body responds to training and protein. Layering an aggressive calorie deficit onto that window without a loading stimulus and adequate protein is a combination worth taking seriously rather than doing by accident.
Our Genomic Menopause Reset exists for this reason. It looks at genomic and biomarker data to build the nutrition, training, and recovery plan around what's actually happening for that person, with provider oversight for anything clinical. It isn't a treatment for menopause, and it doesn't replace care from a gynecologist or primary care physician. It's a structured program for the strength, nutrition, and measurement side.
Local FAQ: Dartmouth and the SouthCoast
Where is Vitality Dartmouth?
We're in Dartmouth, MA, and we see patients in person. Most of the people we work with come from Dartmouth, New Bedford, Westport, Fairhaven, Fall River, and the surrounding SouthCoast communities.
Do I need to already be on a medication to work with you?
No. Plenty of people start with lab and genomic testing plus a nutrition and training program and never take a weight-loss medication at all. Others come in already prescribed elsewhere and want the strength and nutrition structure around it. Whether medication is appropriate is a provider decision made after screening.
Can you help if I've stopped a GLP-1 and regained weight?
That's one of the most common conversations we have. The post-medication phase is where lean mass and training habits decide what happens, and it's worth building a plan for before you taper rather than after.
Do you take insurance?
We're cash-pay. Some patients use HSA or FSA funds. Check with your plan administrator, and ask your prescribing provider whether a Letter of Medical Necessity applies to your situation.
Where to start
If you're on a weight-loss medication now, or considering one, the question worth answering isn't how fast the scale moves. It's how much of what you lose is fat, and what you'll be standing on when the medication stops.
with Vitality Dartmouth in Dartmouth, MA. It's a conversation about your history, your goals, and whether this is a fit. No clinical services are bundled into it, and state of residence gets verified before we schedule.
You can also read more about our Longevity and Vitality Protocol, or our earlier piece on peptides and tissue repair.
This article is educational and is not medical advice. It doesn't diagnose, treat, cure, or prevent any condition, and it isn't a substitute for care from your physician or another qualified provider. Justin Coelho is a registered nurse and does not prescribe, diagnose, or independently order diagnostic testing. All prescriptions and lab orders at Vitality Dartmouth are written by a collaborating nurse practitioner or physician. Individual results vary. Talk with your own provider before starting, stopping, or changing any medication, supplement, or exercise program.